Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q2 FY21 results · Jul–Sep 2020

Insecticides (India) reported revenue from operations of ₹455.85 crore (down 9.4% from Q2 FY20) and net profit of ₹41.61 crore (down 15.1% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY21Q2 FY20YoYQ1 FY21QoQ
Revenue from operations455.85503.10−9.4%409.60+11.3%
Other income5.051.76+186.6%1.12+349.1%
Total income460.90504.87−8.7%410.72+12.2%
Profit before share of associates & JVs and tax55.2062.10−11.1%31.99+72.6%
Share of profit/(loss) of associates & JVs0.210.210.28
Net profit for the period41.6149.02−15.1%24.36+70.8%
EPS, basic (₹)20.1323.72−15.1%11.79+70.7%
Net margin (%)9.19.75.9

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ2 FY21Q2 FY20YoYQ1 FY21QoQ
Revenue from operations455.85503.10−9.4%409.60+11.3%
Other income5.051.76+186.6%1.12+349.1%
Total income460.90504.87−8.7%410.72+12.2%
Profit before tax55.2062.10−11.1%31.99+72.6%
Net profit for the period41.4048.81−15.2%24.08+71.9%
EPS, basic (₹)20.0323.61−15.2%11.65+71.9%
Net margin (%)9.19.75.9
Consolidated
Filed with BSE
11 Nov 2020, 12:41 IST
Board meeting
09 Nov 2020
Period
01 Jul 2020 to 30 Sep 2020
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
11 Nov 2020, 12:41 IST
Board meeting
09 Nov 2020
Period
01 Jul 2020 to 30 Sep 2020
Review status
Unaudited
Source
XBRL filing on BSE